UNSPSC 85653035: Supplement right lower leg muscle with synthetic substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right lower leg muscle with synthetic substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0KUS4JZ

UNSPSC 85653035 Supplement right lower leg muscle with synthetic substitute, percutaneous endoscopic approach is a Commodity code showing little relevant recent activity under its nominal medical-procedure scope. The recent opportunities tagged to this code do not involve lower leg muscle supplementation or percutaneous endoscopic procedures; instead, they span occupational medical surveillance, pharmacy benefit management, temporary health professional staffing, independent medical evaluations for disability benefit determinations, surgical carve-out programs, and emergency services for detained youth. The mismatch suggests this code is either rarely used by state and local procurement offices or has been misapplied to these records by the tagging system.

The issuing bodies across the recent records include county health systems (Santa Clara, Harris County, Collier County), a state transportation department (Washington State Department of Transportation), and municipal retirement boards (City of Phoenix). Geographic activity spans California, Florida, Washington, Arizona, and Texas, with no strong concentration. Representative recent opportunities include the Washington State Department of Transportation's occupational medical surveillance RFP (response due October 9, 2026), the City of Phoenix Retirement Office's independent medical evaluation services RFP (response due October 16, 2026 at $750,000 maximum over five years), and the County of Santa Clara Health System's temporary health professional staffing qualification RFP (response due October 7, 2026). None of these align with the code's stated scope of lower leg muscle supplementation via endoscopic approach.